Back
Theravance Biopharma Vs. Vanda Pharmaceuticals Industry Stock Comparison
Sell
28
TBPH
Theravance Biopharma
Last Price:
9.26
Seasonality Move:
-9.27%
Buy
56
VNDA
Vanda Pharmaceuticals
Last Price:
5.49
Seasonality Move:
5.49%
Sell
28
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $9.29. The Score for TBPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- TBPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Vanda Pharmaceuticals (VNDA)
is a Buy
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $5.48. The Score for VNDA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- VNDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $5.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNDA is experiencing selling pressure, which indicates risk of future bearish movement.
TBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 48.81 | Sell |
| Chaikin Money Flow: | -238819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.05 - 9.67) | Sell |
| Bollinger Bands (100): | (8.64 - 10.1) | Sell |
VNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 62.7 | Buy |
| Chaikin Money Flow: | -716416 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.52 - 5.3) | Buy |
| Bollinger Bands (100): | (3.78 - 4.78) | Buy |
TBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.51 | Sell |
| 20-day SMA: | 9.32 | Sell |
| 50-day SMA: | 9.17 | Buy |
| 200-day SMA: | 9.59 | Sell |
| 8-day EMA: | 9.48 | Sell |
| 20-day EMA: | 9.39 | Sell |
| 50-day EMA: | 9.3 | Sell |
| 200-day EMA: | 9.61 | Sell |
VNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.25 | Buy |
| 20-day SMA: | 4.97 | Buy |
| 50-day SMA: | 4.5 | Buy |
| 200-day SMA: | 4.39 | Buy |
| 8-day EMA: | 5.28 | Buy |
| 20-day EMA: | 5.03 | Buy |
| 50-day EMA: | 4.68 | Buy |
| 200-day EMA: | 4.79 | Buy |
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Theravance Biopharma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vanda Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||